tiprankstipranks
Trending News
More News >
IRLAB Therapeutics AB Class A (SE:IRLAB.A)
:IRLAB.A

IRLAB Therapeutics AB Class A (IRLAB.A) Revenue

Compare
1 Followers

IRLAB Therapeutics AB Class A Revenue

IRLAB Therapeutics AB Class A had a revenue of 18.85M in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 85.56M, Decreased 12.96%. In the fiscal year ending Dec 31, 2024, IRLAB Therapeutics AB Class A had annual revenue of 94.63M with 1566.57% growth.
Revenue (ttm)
85.56M
Revenue Growth
69.03%
P/S Ratio
1.72
Revenue/Employee
kr3,052,516
Employees
31
Market Cap
kr162.74M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
94.63M88.95M+1,666.57%
Dec 31, 2023
5.68M-55.46M+9.29%
Dec 31, 2022
61.14M-146.65M+29.42%
Dec 31, 2021
207.78M207.48M+69,260.90%
Dec 31, 2020
300.00K274.00K+1,153.89%
Dec 31, 2019
26.00K8.00K+144.45%
Dec 31, 2018
18.00K-91.00K+16.51%
Dec 31, 2017
109.00K-35.00K+75.69%
Dec 31, 2016
144.00K